273 related articles for article (PubMed ID: 25881026)
21. Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial.
Bjöhle J; Bergqvist J; Gronowitz JS; Johansson H; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Söderberg M; Sundquist M; Walz TM; Fernö M; Bergh J; Hatschek T
Breast Cancer Res Treat; 2013 Jun; 139(3):751-8. PubMed ID: 23736998
[TBL] [Abstract][Full Text] [Related]
22. Liquid chromatography-tandem mass spectrometry method for quantification of thymidine kinase activity in human serum by monitoring the conversion of 3'-deoxy-3'-fluorothymidine to 3'-deoxy-3'-fluorothymidine monophosphate.
Faria M; Halquist MS; Kindt E; Li W; Karnes HT; O'Brien PJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():13-20. PubMed ID: 22995377
[TBL] [Abstract][Full Text] [Related]
23. Serum thymidine kinase 1 activity in breast cancer.
Nisman B; Allweis T; Kaduri L; Maly B; Gronowitz S; Hamburger T; Peretz T
Cancer Biomark; 2010; 7(2):65-72. PubMed ID: 21178264
[TBL] [Abstract][Full Text] [Related]
24. Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients.
Nisman B; Allweis T; Kadouri L; Mali B; Hamburger T; Baras M; Gronowitz S; Peretz T
Clin Chem Lab Med; 2013 Feb; 51(2):439-47. PubMed ID: 23093267
[TBL] [Abstract][Full Text] [Related]
25. Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer.
Tribukait B; Lundgren PO; Kjellman A; Norming U; Nyman CR; Jagarlmundi K; Gustafsson O
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982234
[TBL] [Abstract][Full Text] [Related]
26. Can thymidine kinase levels in breast tumors predict disease recurrence?
O'Neill KL; Hoper M; Odling-Smee GW
J Natl Cancer Inst; 1992 Dec; 84(23):1825-8. PubMed ID: 1433372
[TBL] [Abstract][Full Text] [Related]
27. Serological thymidine kinase 1 (STK1) indicates an elevated risk for the development of malignant tumours.
Chen Z; Zhou H; Li S; He E; Hu J; Zhou J; Skog S
Anticancer Res; 2008; 28(6B):3897-907. PubMed ID: 19192647
[TBL] [Abstract][Full Text] [Related]
28. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.
Wang Y; Jiang X; Dong S; Shen J; Yu H; Zhou J; Li J; Ma H; He E; Skog S
Cancer Biomark; 2016 Mar; 16(4):529-36. PubMed ID: 27002755
[TBL] [Abstract][Full Text] [Related]
29. Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes.
Wang Z; Zhang W; Huo B; Dong L; Zhang J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202305
[TBL] [Abstract][Full Text] [Related]
30. Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1.
Wu C; Yang R; Zhou J; Bao S; Zou L; Zhang P; Mao Y; Wu J; He Q
J Immunol Methods; 2003 Jun; 277(1-2):157-69. PubMed ID: 12799048
[TBL] [Abstract][Full Text] [Related]
31. Serum Thymidine Kinase 1 - Potential Prostate Cancer Biomarker: A Clinical Study.
Rezac J; Hanouskova L; Vesely S; Kotaska K; Kantorova A; Linhartova A; Fiala V; Soukup V; Capoun O
Anticancer Res; 2023 Apr; 43(4):1675-1680. PubMed ID: 36974824
[TBL] [Abstract][Full Text] [Related]
32. [Application of serum thymidine kinase 1 of 26 055 cases in health screening for early detection of premalignant/early malignant tumors].
Cao X; Wang Y; Yang P; Zhou H; Liu C; Chen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 39(10):1029-34. PubMed ID: 25355255
[TBL] [Abstract][Full Text] [Related]
33. Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings.
Chen Y; Ying M; Chen Y; Hu M; Lin Y; Chen D; Li X; Zhang M; Yun X; Zhou J; He E; Skog S
Int J Clin Oncol; 2010 Aug; 15(4):359-68. PubMed ID: 20354751
[TBL] [Abstract][Full Text] [Related]
34. Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
He Q; Mao Y; Wu J; Decker C; Merza M; Wang N; Eriksson S; Castro J; Skog S
Int J Oncol; 2004 Oct; 25(4):945-53. PubMed ID: 15375544
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of correlation between serum thymidine kinase 1 and acute myeloid leukemia].
Wang TJ; Sun AN; Wu DP; Li WY; Liang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1095-8. PubMed ID: 24156413
[TBL] [Abstract][Full Text] [Related]
36. Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report.
Nisman B; Nechushtan H; Biran H; Gantz-Sorotsky H; Peled N; Gronowitz S; Peretz T
J Thorac Oncol; 2014 Oct; 9(10):1568-72. PubMed ID: 25521401
[TBL] [Abstract][Full Text] [Related]
37. Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma.
Li Z; Wang Y; Ma J; He J; Zhou J; He E; Skog S
Anticancer Res; 2010 Apr; 30(4):1295-9. PubMed ID: 20530443
[TBL] [Abstract][Full Text] [Related]
38. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody.
He Q; Zou L; Zhang PA; Lui JX; Skog S; Fornander T
Int J Biol Markers; 2000; 15(2):139-46. PubMed ID: 10883887
[TBL] [Abstract][Full Text] [Related]
39. Sensitive nonradiometric method for determining thymidine kinase 1 activity.
Ohrvik A; Lindh M; Einarsson R; Grassi J; Eriksson S
Clin Chem; 2004 Sep; 50(9):1597-606. PubMed ID: 15247154
[TBL] [Abstract][Full Text] [Related]
40. Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker.
Wang L; Sharif H; Saellström S; Rönnberg H; Eriksson S
BMC Vet Res; 2021 Sep; 17(1):316. PubMed ID: 34579716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
